A Phase 3, Multi-Site, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and safety of 2 oral doses of CP-690, 550 and 1 subcuaneous dose of etanercept in subjects with moderate ot severe chronic plaque psoriasis
Laufzeit: 01.01.2011 - 31.12.2012
imported
Kurzfassung
This is a Phase 3, multi-site, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, 12-week study of efficcy and safety of two oral doses of CP690,550
